Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key?
Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? |
|
https://doi.org/10.18632/oncotarget.1179
Gerald Willimsky,
Ulrike Protzer,
Percy Knolle,
and Mathias Heikenwalder
|
| 1117-1118 |
Cancer detection using whole-genome sequencing of cell free DNA
Cancer detection using whole-genome sequencing of cell free DNA |
|
https://doi.org/10.18632/oncotarget.1183
Rebecca J. Leary,
Mark Sausen,
Luis A. Diaz, Jr.,
and Victor E. Velculescu
|
| 1119-1120 |
Regulation of Mdm2 mRNA Stability by RNA-binding Protein RNPC1
Regulation of Mdm2 mRNA Stability by RNA-binding Protein RNPC1 |
|
https://doi.org/10.18632/oncotarget.1185
Jin Zhang,
Enshun Xu,
and Xinbin Chen
|
| 1121-1122 |
Restoring hemidesmosomes to prevent cancer cell invasiveness
Restoring hemidesmosomes to prevent cancer cell invasiveness |
|
https://doi.org/10.18632/oncotarget.1196
S. Pyronnet,
J. Guillermet-Guibert,
and C. Bousquet
|
| 1123-1124 |
ATM is activated in blood monocytes after tumor radiation.
ATM is activated in blood monocytes after tumor radiation. |
|
https://doi.org/10.18632/oncotarget.1286
Andrei V. Gudkov,
and Elena A. Komarova
|
| 1125 |
A new Achilles Heel in breast cancer?
A new Achilles Heel in breast cancer? |
|
https://doi.org/10.18632/oncotarget.1178
George Sflomos,
and Cathrin Brisken
|
| 1126-1127 |
Overcoming treatment resistance in acute promyelocytic leukemia and beyond
Overcoming treatment resistance in acute promyelocytic leukemia and beyond |
|
https://doi.org/10.18632/oncotarget.1244
Tsz Kan Fung,
and Chi Wai Eric So
|
| 1128-1129 |
Understanding the role of NRF2-regulated miRNAs in human malignancies
Understanding the role of NRF2-regulated miRNAs in human malignancies |
|
https://doi.org/10.18632/oncotarget.1181
Niraj M Shah,
Stuart A Rushworth,
Megan Y Murray,
Kristian M Bowles,
and David J MacEwan
|
| 1130-1142 |
Radiation therapy induces the DNA damage response in peripheral blood
Radiation therapy induces the DNA damage response in peripheral blood |
|
https://doi.org/10.18632/oncotarget.1084
Christopher J Bakkenist,
R Kenneth Czambel,
David A Clump,
Joel S Greenberger,
Jan H Beumer,
and John C Schmitz
|
| 1143-1148 |
Gli1 Transcriptional Activity is Negatively Regulated by AKT2 in Neuroblastoma
Gli1 Transcriptional Activity is Negatively Regulated by AKT2 in Neuroblastoma |
|
https://doi.org/10.18632/oncotarget.1074
Pritha Paul,
Natasha S. Volny,
Sora Lee,
Jingbo Qiao,
and Dai H. Chung
|
| 1149-1157 |
Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis.
Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis. |
|
https://doi.org/10.18632/oncotarget.1093
Limin Wang,
Kathleen A Gallo,
and Susan E Conrad
|
| 1158-1171 |
Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target
Identification of pregnancy-associated plasma protein A as a migration-promoting gene in malignant pleural mesothelioma cells: a potential therapeutic target |
|
https://doi.org/10.18632/oncotarget.1126
Jun Huang,
Sho Tabata,
Soji Kakiuchi,
Trung The Van,
Hisatsugu Goto,
Masaki Hanibuchi,
and Yasuhiko Nishioka
|
| 1172-1184 |
Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling
Combining TRAIL with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling |
|
https://doi.org/10.18632/oncotarget.1162
Grazia Saturno,
Melanie Valenti,
Alexis De Haven Brandon,
George V. Thomas,
Suzanne Eccles,
Paul A. Clarke,
and Paul Workman
|
| 1185-1198 |
Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis |
|
https://doi.org/10.18632/oncotarget.1122
Noor A. Lokman,
Alison SF. Elder,
Miranda P Ween,
Carmen E. Pyragius,
Peter Hoffmann,
Martin K. Oehler,
and Carmela Ricciardelli
|
| 1199-1211 |
Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via Unfolded Protein Response Signaling
Small Molecule-Induced Mitochondrial Disruption Directs Prostate Cancer Inhibition via Unfolded Protein Response Signaling |
|
https://doi.org/10.18632/oncotarget.1130
Elizabeth Rico-Bautista,
Wenhong Zhu,
Shinichi Kitada,
Suthakar Ganapathy,
Eric Lau,
Stan Krajewski,
Joel Ramirez,
Jason A. Bush,
Zhimin Yuan,
and Dieter A. Wolf
|
| 1212-1229 |
Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival
Clonogenic multiple myeloma cells have shared stemness signature associated with patient survival |
|
https://doi.org/10.18632/oncotarget.1145
Renji Reghunathan,
Chonglei Bi,
Shaw Cheng Liu,
Koh Tze Loong,
Tae-Hoon Chung,
Gaofeng Huang,
and Wee Joo Chng
|
| 1230-1240 |
A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration
A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration |
|
https://doi.org/10.18632/oncotarget.1147
Judith Hagenbuchner,
Ursula Kiechl-Kohlendorfer,
Petra Obexer,
and Michael J. Ausserlechner
|
| 1241-1252 |
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer |
|
https://doi.org/10.18632/oncotarget.1141
Alessia Noto,
Claudia De Vitis,
Giuseppe Roscilli,
Luigi Fattore,
Debora Malpicci,
Emanuele Marra,
Laura Luberto,
Antonio D'Andrilli,
Pierpaolo Coluccia,
Maria Rosaria Giovagnoli,
Nicola Normanno,
Luigi Ruco,
Luigi Aurisicchio,
Rita Mancini,
and Gennaro Ciliberto
|
| 1253-1265 |
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1
PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1 |
|
https://doi.org/10.18632/oncotarget.1164
Alexander Gont,
Jennifer E. L. Hanson,
Sylvie J. Lavictoire,
Doris A. E. Parolin,
Manijeh Daneshmand,
Ian J. restall,
Mathieu Soucie,
Garth Nicholas,
John Woulfe,
Amin Kassam,
Vasco F. Da Silva,
and Ian A. J. Lorimer
|
| 1266-1279 |
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells.
Critical role of zinc finger protein 521 in the control of growth, clonogenicity and tumorigenic potential of medulloblastoma cells. |
|
https://doi.org/10.18632/oncotarget.1176
Raffaella Spina,
Gessica Filocamo,
Enrico Iaccino,
Stefania Scicchitano,
Michela Lupia,
Emanuela Chiarella,
Tiziana Mega,
Francesca Bernaudo,
Daniela Pelaggi,
Maria Mesuraca,
Simonetta Pazzaglia,
Samantha Semenkow,
Eli E Bar,
Marcel Kool,
Stefan Pfister,
Heather M Bond,
Charles G Eberhart,
Christian Steinkühler,
and Giovanni Morrone
|
| 1280-1292 |
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness |
|
https://doi.org/10.18632/oncotarget.1136
Silvia Pegoraro,
Gloria Ros,
Silvano Piazza,
Roberta Sommaggio,
Yari Ciani,
Antonio Rosato,
Riccardo Sgarra,
Giannino Del Sal,
and Guidalberto Manfioletti
|
| 1293-1308 |
Cancer Metabolism: New Validated Targets for Drug Discovery
Cancer Metabolism: New Validated Targets for Drug Discovery |
|
https://doi.org/10.18632/oncotarget.1182
Federica Sotgia,
Ubaldo E. Martinez-Outschoorn,
and Michael P Lisanti
|
| 1309-1316 |
A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions
A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions |
|
https://doi.org/10.18632/oncotarget.1170
Jeff C. Liu,
Sean E. Egan,
and Eldad Zacksenhaus
|
| 1317-1328 |
